bexarotene has been researched along with Hypothyroidism in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (8.70) | 18.2507 |
| 2000's | 11 (47.83) | 29.6817 |
| 2010's | 8 (34.78) | 24.3611 |
| 2020's | 2 (8.70) | 2.80 |
| Authors | Studies |
|---|---|
| Zic, JA | 1 |
| Emoto, M; Hayashi, D; Imanishi, Y; Inaba, M; Kurajoh, M; Miyaoka, D; Morita, A; Nagata, Y; Tateishi, C; Toi, N; Tsuruta, D; Yamada, S | 1 |
| Hamada, T; Iwatsuki, K; Kawai, K; Kiyohara, E; Matsushita, S; Nagatani, T; Ohtsuka, M; Saida, T; Setoyama, M; Sugaya, M; Tani, M; Tokura, Y; Tsuboi, R; Yonekura, K | 1 |
| Appetecchia, M; Baldelli, R; Barnabei, A; Corsello, SM; Paragliola, R; Torino, F | 1 |
| Atmaca, H; Islek, I; Sentürk, N | 1 |
| Huen, AO; Kim, EJ | 1 |
| Garcia Morillo, JS; Muñiz Grijalvo, O; Pamies Andreu, E; Rodriguez Suarez, S | 1 |
| Abbott, L; Farah, R; Gopaluni, S; Hutchison, R; Perzova, R; Poiesz, BJ; Shrimpton, A | 1 |
| Bair, SM; Cherpelis, BS; Fenske, NA; Glass, LF; Marquez, CB; Smithberger, EE; Wenham, RM | 1 |
| Haugen, BR | 1 |
| Alvarado, CS; Busam, KJ; Hale, GA; Horwitz, S; Jaffe, ES; Kim, YH; Mehta, N; Myskowski, P; Pulitzer, M; Wayne, AS; Zwerner, J | 1 |
| Hamnvik, OP; Larsen, PR; Marqusee, E | 1 |
| Hahtola, S; Ranki, A; Väkevä, L | 1 |
| Apisarnthanarax, N; Breuer-Mcham, J; Duvic, M; Talpur, R; Ward, S | 1 |
| Sherman, SI | 1 |
| Corcoy, R; García-Muret, MP; Rodríguez, J; Sucunza, N | 1 |
| Assaf, C; Bagot, M; Dummer, R; Duvic, M; Gniadecki, R; Knobler, R; Ranki, A; Schwandt, P; Whittaker, S | 1 |
| Pereira, AM; Romijn, JA; Smit, JW; Stokkel, MP; Visser, TJ | 1 |
| Avilés Pérez, MD; de Argila Fernández-Durán, D; Díaz Pérez de Madrid, J; Luna López, V; Rodríguez Nevado, I | 1 |
| Chiu, AC; Duvic, M; Gopal, J; Haugen, BR; Nowlakha, P; Sherman, SI; Whaley, K | 1 |
| Asteria, C | 1 |
9 review(s) available for bexarotene and Hypothyroidism
| Article | Year |
|---|---|
Diagnosis and Management of Cutaneous Lymphomas Including Cutaneous T-cell Lymphoma.
Topics: Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Antineoplastic Agents, Immunological; Arthropods; Bexarotene; Bites and Stings; Brentuximab Vedotin; Diagnosis, Differential; Humans; Hyperlipidemias; Hypothyroidism; Lymphoma, Primary Cutaneous Anaplastic Large Cell; Lymphoma, T-Cell, Cutaneous; Lymphomatoid Papulosis; Mycosis Fungoides; Peripheral Nervous System Diseases; Prognosis; Sezary Syndrome; Skin Diseases; Skin Neoplasms | 2021 |
Thyroid dysfunction as an unintended side effect of anticancer drugs.
Topics: Alemtuzumab; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bexarotene; Diphtheria Toxin; Humans; Hypothyroidism; Interferon-alpha; Interleukin-2; Lenalidomide; Neoplasms; Recombinant Fusion Proteins; Tetrahydronaphthalenes; Thalidomide; Thyroid Diseases; Thyroid Gland; Thyroid Hormones; Thyroxine | 2013 |
The Role of Systemic Retinoids in the Treatment of Cutaneous T-Cell Lymphoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Combined Modality Therapy; Humans; Hyperlipidemias; Hypothyroidism; Immunologic Factors; Interferons; Mycosis Fungoides; PUVA Therapy; Retinoids; Sezary Syndrome; Skin Neoplasms; Tetrahydronaphthalenes | 2015 |
CD8+ cutaneous T-cell lymphoma successfully treated with bexarotene: a case report and review of the literature.
Topics: Antineoplastic Agents; Azetidines; Bexarotene; Carcinoma, Renal Cell; CD8-Positive T-Lymphocytes; Contraindications; Exanthema; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Hypothyroidism; Incidental Findings; Kidney Neoplasms; Male; Middle Aged; Mycosis Fungoides; Neoplasms, Multiple Primary; Simvastatin; Skin Neoplasms; Tetrahydronaphthalenes; Thyroxine | 2008 |
Drugs that suppress TSH or cause central hypothyroidism.
Topics: Aged; Bexarotene; Dopamine Agonists; Glucocorticoids; Humans; Hypothyroidism; Lymphoma, T-Cell; Male; Metformin; Retinoid X Receptors; Somatostatin; Tetrahydronaphthalenes; Thyrotropin | 2009 |
Thyroid dysfunction from antineoplastic agents.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Anticarcinogenic Agents; Antineoplastic Agents; Bexarotene; Diphtheria Toxin; Humans; Hyperthyroidism; Hypopituitarism; Hypothyroidism; Interferon-alpha; Interleukin-2; Iodine Radioisotopes; Ipilimumab; Lenalidomide; Molecular Targeted Therapy; Neoplasms; Protein-Tyrosine Kinases; Quality of Life; Radioimmunotherapy; Recombinant Fusion Proteins; Recombinant Proteins; Tetrahydronaphthalenes; Thalidomide; Thyroid Function Tests; Thyroid Gland; Thyroid Hormones; Thyroiditis, Autoimmune | 2011 |
Etiology, diagnosis, and treatment recommendations for central hypothyroidism associated with bexarotene therapy for cutaneous T-cell lymphoma.
Topics: Anticarcinogenic Agents; Bexarotene; Humans; Hypothyroidism; Lymphoma, T-Cell, Cutaneous; Skin Neoplasms; Tetrahydronaphthalenes; Thyrotropin | 2003 |
Minimizing adverse side-effects of oral bexarotene in cutaneous T-cell lymphoma: an expert opinion.
Topics: Anticarcinogenic Agents; Bexarotene; Humans; Hyperlipidemias; Hypolipidemic Agents; Hypothyroidism; Lymphoma, T-Cell, Cutaneous; Skin Neoplasms; Tetrahydronaphthalenes; Thyroxine | 2006 |
Treatment with retinoid X receptorgamma-selective ligand (bexarotene) may cause iatrogenic central hypothyroidism.
Topics: Animals; Bexarotene; Humans; Hypothyroidism; Iatrogenic Disease; Lymphoma, T-Cell; Retinoids; Skin Neoplasms; Tetrahydronaphthalenes | 2000 |
2 trial(s) available for bexarotene and Hypothyroidism
| Article | Year |
|---|---|
Long-term efficacy and safety of bexarotene for Japanese patients with cutaneous T-cell lymphoma: The results of a phase 2 study (B-1201).
Topics: Adult; Antineoplastic Agents; Bexarotene; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Hypertriglyceridemia; Hypothyroidism; Japan; Leukopenia; Lymphoma, Primary Cutaneous Anaplastic Large Cell; Male; Mycosis Fungoides; Neoplasm Staging; Neutropenia; Skin Neoplasms; Time Factors; Young Adult | 2019 |
Bexarotene-induced hypothyroidism: bexarotene stimulates the peripheral metabolism of thyroid hormones.
Topics: Aged; Anticarcinogenic Agents; Bexarotene; Drug Evaluation, Preclinical; Female; Humans; Hypothyroidism; Lung Neoplasms; Male; Middle Aged; Retinoid X Receptors; Tetrahydronaphthalenes; Thyroid Hormones; Thyroid Neoplasms; Thyrotropin; Thyroxine; Triiodothyronine | 2007 |
12 other study(ies) available for bexarotene and Hypothyroidism
| Article | Year |
|---|---|
Bexarotene-induced central hypothyroidism assessed by TRH stimulation test in cutaneous T-cell lymphoma patients.
Topics: Bexarotene; Humans; Hypothyroidism; Lymphoma, T-Cell, Cutaneous; Retrospective Studies; Skin Neoplasms; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Triiodothyronine | 2022 |
Reversible pituitary insufficiency due to bexarotene therapy in a patient with mycosis fungoides.
Topics: Adrenal Insufficiency; Anticarcinogenic Agents; Bexarotene; Humans; Hypertriglyceridemia; Hypogonadism; Hypopituitarism; Hypothyroidism; Male; Middle Aged; Mycosis Fungoides; Tetrahydronaphthalenes | 2014 |
[Thyroid and lipidic dysfunction associated with bexarotene in cutaneous T-cell lymphoma].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Cholesterol, HDL; Combined Modality Therapy; Humans; Hyperlipidemias; Hypolipidemic Agents; Hypothyroidism; Male; Middle Aged; Mycosis Fungoides; Peripheral Blood Stem Cell Transplantation; Radiotherapy, Adjuvant; Salvage Therapy; Sezary Syndrome; Skin Neoplasms; Tetrahydronaphthalenes; Thyroxine | 2016 |
Multiple keratoacanthomas arising in the setting of sorafenib therapy: novel chemoprophylaxis with bexarotene.
Topics: Adenocarcinoma, Papillary; Anticarcinogenic Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Bexarotene; Carboplatin; Clinical Trials as Topic; Cystadenocarcinoma, Serous; Dose-Response Relationship, Drug; Female; Humans; Hypertriglyceridemia; Hypothyroidism; Keratoacanthoma; Middle Aged; Neoplasm Recurrence, Local; Niacinamide; Ovarian Neoplasms; Paclitaxel; Phenylurea Compounds; Pyridines; Skin Diseases; Sorafenib; Tetrahydronaphthalenes | 2009 |
Bexarotene is active against subcutaneous panniculitis-like T-cell lymphoma in adult and pediatric populations.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticarcinogenic Agents; Bexarotene; Child; Child, Preschool; Diabetes Mellitus, Type 1; Disease-Free Survival; Female; Humans; Hyperlipidemias; Hypertriglyceridemia; Hypothyroidism; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasm Staging; Panniculitis; Skin Neoplasms; Tetrahydronaphthalenes; Treatment Outcome; Young Adult | 2012 |
Ten-year experience of bexarotene therapy for cutaneous T-cell lymphoma in Finland.
Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Anticarcinogenic Agents; Aspartate Aminotransferases; Bexarotene; Combined Modality Therapy; Finland; Humans; Hypercholesterolemia; Hypertriglyceridemia; Hypothyroidism; Liver; Lymphoma, T-Cell, Cutaneous; Middle Aged; Neoplasm Staging; Neutropenia; Retrospective Studies; Skin Neoplasms; Tetrahydronaphthalenes | 2012 |
Optimizing bexarotene therapy for cutaneous T-cell lymphoma.
Topics: Algorithms; Anticarcinogenic Agents; Bexarotene; Dermatitis, Exfoliative; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Hypothyroidism; Middle Aged; Mycosis Fungoides; Photopheresis; Prospective Studies; Skin Neoplasms; Tetrahydronaphthalenes; Treatment Outcome | 2002 |
[Central hypothyroidism related with bexarotene treatment].
Topics: Anticarcinogenic Agents; Bexarotene; Female; Humans; Hypothyroidism; Middle Aged; Tetrahydronaphthalenes | 2005 |
[Treatment of cutaneous T-cell lymphoma with retinoid receptor X-selective ligands: endocrine and metabolic disorders].
Topics: Anticarcinogenic Agents; Bexarotene; Dyslipidemias; Female; Humans; Hypothyroidism; Ligands; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Retinoid X Receptors; Skin Neoplasms; Tetrahydronaphthalenes | 2007 |
Central hypothyroidism associated with retinoid X receptor-selective ligands.
Topics: Aged; Bexarotene; Cohort Studies; Humans; Hypothyroidism; Ligands; Lymphoma, T-Cell, Cutaneous; Male; Promoter Regions, Genetic; Receptors, Retinoic Acid; Retinoid X Receptors; Retinoids; Tetrahydronaphthalenes; Thyroid Function Tests; Thyroid Gland; Thyrotropin; Transcription Factors | 1999 |
New genetic mechanism associated with thyroid-related diseases.
Topics: Anticarcinogenic Agents; Bexarotene; Female; Humans; Hypothyroidism; Incidence; Male; Neoplasms; Tetrahydronaphthalenes; Thyroid Gland; Thyroid Hormones; Thyrotropin; United States | 1999 |
Bexarotene (Targretin) for cutaneous T-cell lymphoma.
Topics: Bexarotene; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Interactions; Fees, Pharmaceutical; Half-Life; Humans; Hypertriglyceridemia; Hypothyroidism; Lymphoma, T-Cell, Cutaneous; Receptors, Retinoic Acid; Retinoids; Tetrahydronaphthalenes | 2000 |